TOKYO, Aug. 29, 2018 /PRNewswire/ — KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by…

View more at https://www.prnewswire.com:443/news-releases/kinopharma-and-national-institutes-for-quantum-and-radiological-science-and-technology-launch-collaborative-research-project-for-exploring-new-drug-development-for-alzheimers-disease-300703858.html